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Obstructive sleep apnea syndrome in children: 
Epidemiology, pathophysiology, diagnosis and 
sequelae
The prevalence of pediatric obstructive sleep apnea syndrome (OSAS) 
is approximately 3% in children. Adenotonsillar hypertrophy is the 
most common cause of OSAS in children, and obesity, hypotonic 
neuromuscular diseases, and craniofacial anomalies are other major 
risk factors. Snoring is the most common presenting complaint in 
children with OSAS, but the clinical presentation varies according 
to age. Agitated sleep with frequent postural changes, excessive 
sweating, or abnormal sleep positions such as hyperextension of 
neck or abnormal prone position may suggest a sleep-disordered 
breathing. Night terror, sleepwalking, and enuresis are frequently 
associated, during slow-wave sleep, with sleep-disordered breathing. 
Excessive daytime sleepiness becomes apparent in older children, 
whereas hyperactivity or inattention is usually predominant in younger 
children. Morning headache and poor appetite may also be present. 
As the cortical arousal threshold is higher in children, arousals are 
not easily developed and their sleep architectures are usually more 
conserved than those of adults. Untreated OSAS in children may 
result in various problems such as cognitive deficits, attention deficit/
hyperactivity disorder, poor academic achievement, and emotional 
instability. Mild pulmonary hypertension is not uncommon. Rarely, 
cardiovascular complications such as cor pulmonale, heart failure, 
and systemic hypertension may develop in untreated cases. Failure 
to thrive and delayed development are serious problems in younger 
children with OSAS. Diagnosis of pediatric OSAS should be based 
on snoring, relevant history of sleep disruption, findings of any 
narrow or collapsible portions of upper airway, and confirmed by 
polysomnography. Early diagnosis of pediatric OSAS is critical to 
prevent complications with appropriate interventions.
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Introduction
Obstructive sleep apnea syndrome (OSAS) is defined as a 
disorder of breathing during sleep characterized by prolonged 
partial airway obstruction and/or intermittent complete obstruction 
(obstructive apnea) that interrupts normal ventilation during sleep 
and normal sleep patterns
1). OSAS is usually considered as an 
extreme of “sleep-disordered breathing” spectrum encompassing 
primary snoring, upper airway resistance syndrome, obstructive 
hypoventilation, and OSAS. Sleep-disordered breathing occurs 
during sleep and is exacerbated by sleep
2). Primary snoring occurs 
when snoring is not associated with ventilatory abnormalities 
such as apnea, hypopnea, hypoxia, or hypercapnia
3). Upper 
airway resistance syndrome is characterized by increasing negative 
intrathoracic pressure during inspiration without apparent apneic 
or hypopneic events, resulting in increased respiratory arousals 
leading to increased sleep fragmentation and daytime sleepiness. 
Obstructive hypoventilation is common in obese children, and 
diagnosed by snoring, reduced ventilatory drive with hypercapnea 
without apparent sleep apneas, or respiratory arousals
4). Untreated 
sleep-disordered breathing in children has been reported to be 
related with various problems such as attention deficit/hyperactivity 
disorder, poor academic achievement, and behavioral problems. It 
may even cause more serious morbidities, such as growth failure, cor 
pulmonale, and systemic hypertension
5). Moreover, recent studies 
suggest that primary snoring may not be as innocuous as previously 
thought, with learning, neurocognitive, and behavioral deficits 
being described in children who snore
6, 7). This article reviews the 
prevalence, pathophysiology, and diagnosis of OSAS in children 
to improve the understanding of pediatric OSAS, and to promote 
early diagnosis and treatment to prevent serious complications. 
Epidemiology
The prevalence of habitual snoring extremely varies, from 3% 
to 35% of children under 13 years of age, due to the differ  ent 
definition of habitual snoring and epidemiologic methodologies
8, 
9); however, it has been mostly reported in 8-12% of children from 
2 to 8 years of age
10-13). OSAS has been estimated to affect about 
2-3.5% of children
8,13,14). OSAS prevalence has 2 peak periods. 
The first peak occurs in children from 2 to 8 years of age, with the 
presence of enlarged adenoid and/or tonsils. A second peak arises 
during adolescence in relation with weight gain. Although gender 
differences have not been observed in the prevalence of OSAS 
among prepubertal children, some adolescent boys has been more 
affected than girls in a few reports
12). In adults, most studies have 
estimated a sex-specific prevalence of a 2- to 3-fold greater risk 
for men than women
15). In an epidemiologic study for Korean 
adolescents from 15 to 18 years of age, the prevalence of snoring 
and OSAS were 11.2% and 0.9%, respectively. Snoring was more 
common in boys (12.4% in boys vs. 8.5% in girls)
11). The prevalence 
of sleep-disordered breathing in Korean children has not been 
reported. 
Pathophysiology of Childhood OSAS
The upper airway consists of the nose, pharynx, larynx, and 
extrathoracic trachea, which have important physiologic functions 
such as respiration, swallowing, speech and vibration, and local 
immunity. The pharynx is a collapsible segment that performs these 
functions under the balanced control of dilator and constrictor 
muscles. During the waking state, upper airway collapse is 
prevented by keeping an increased pharyngeal neuromuscular 
tone
16). This mechanism, however, is attenuated during sleep, 
predisposing the upper airway to collapse
17).
The main risk factors for OSAS in adults are obesity and male 
sex, which are related to the propensity for repetitive upper airway 
collapse
18). In younger children, the major risk factor for the 
development of OSAS is adenotonsillar hypertrophy
19). Adenoid 
and tonsils grow progressively during childhood
20-22), whereas the 
skeletal boundaries of the upper airway slowly expand. Between 
the ages of 3 and 8 years, the tonsils and adenoid are largest in 
relation to the underlying upper airway size, which makes a narrow 
upper airway. This size disparity coincides with the peak incidence 
of pediatric OSAS
5). Neuromuscular factors for upper airway 
patency are affected by central ventilatory drive, arousal responses 
to respiratory occlusion (arousal threshold), and upper airway 
reflexes
23, 24). It is suggested that central ventilatory drive is increased 
during childhood and then declines gradually with age
25, 26). This 
increased central ventilatory drive during sleep accounts for the 
increased upper airway reflexes and tone in children, resulting in less 
collapsibility than in adults. Thus, children have a specific breathing 
pattern of obstructive hypoventilation rather than discrete, cyclic 
obstructive pattern that is commonly seen in adult sleep-disordered 
breathing
27). Children also have a higher arousal threshold than 
adults; the younger the child, the higher the threshold of arousal
28). 
Children are, therefore, less likely to arouse in response to upper 
airway obstruction than adults, accounting for the preservation of 
sleep architecture
29). 
In obese children, excessive deposition of fat tissue within 
the muscles and tissue surrounding the upper airway leads to 
reduced airway size and increased airway resistance
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lung volumes and decreased central ventilatory drive in obese 
children also contribute to compromised upper airway patency
30). 
Nowadays, obesity is a major cause of pediatric OSAS in the 
western countries due to the dramatic increase of the prevalence of 
obesity in children. A large epidemiologic study showed that obesity 
is the most significant risk factor for developing OSAS in children 
between 2 and 18 years of age, with an odds ratio of 4.5
31). Recently, 
it is suggested that pediatric OSAS with obesity would be classified 
as “pediatric OSAS type 2” since it has similar clinical features with 
adult OSAS
32).
Nasal mucosal edema induced by allergic rhinitis, which increase 
nasal resistance, may also exacerbate or induce sleep-breathing 
disorder in children and adolescents
1). Craniofacial anomalies such 
as midfacial hypoplasia, small nasopharynx, and/or micrognathia in 
Pierre Robin sequence, Apert syndrome, and Marfan syndrome are 
also important risk factors for developing OSAS
19). OSAS presents 
in 30% to 60% of individuals with Down syndrome, related with 
decreased nasopharyngeal surface area, ventilatory volume, and 
hypotonia
19, 33, 34). Hypothyroidism, a frequent complication of 
Down syndrome, is another risk factor, which leads to hypotonia. 
Neuromuscular disease such as progressive muscular dystrophy is 
related with reduced upper airway muscle tone, resulting in upper 
airway collapse. 
Genetic Risk Factors
Genetic risk factors have been identified in the development of 
OSAS
35). Asian adults tend to have more severe OSAS for an even 
lesser degree of obesity than Caucasians
36). The short skull base has 
been noted as an ethnic risk factor in Asians. Asian children also 
have more severe OSAS than Caucasians, although prevalence 
is relatively lower
37). In African Americans, thick soft tissue 
dimensions such as tongue mass and oral mucosa are risk factors for 
OSAS. African American children have been shown to have 4- to 
6-fold higher risks than white children, independent of other factors 
such as obesity, premature birth, and maternal smoking
38). 
Clinical Manifestations
A wide range of symptoms and signs are associated with OSAS 
in children depending on their developmental stages (Table 1)
39). 
Snoring is the most common presenting complaint of children and 
adolescents with OSAS. Parents may describe chest wall retractions, 
paradoxical breathing, and sometimes pauses in breathing. Restless 
sleep with frequent changes of body position is also well described 
among children with OSAS, although many parents consider it 
a normal behavior during sleep in childhood. Excessive sweating 
during sleep may be related with labored breathing. Abnormal 
sleep positions such as hyperextension of the neck in infants and 
abnormal prone position may indicate the possibility of having 
sleep-disordered breathing. Night terror and sleepwalking are 
frequently accompanied by sleep-disordered breathing during 
slow-wave sleep in children and adolescents with a positive family 
history of parasomnias
40). Children with OSAS are high risk for 
enuresis, which may resolve when the OSAS is adequately treated
41). 
Excessive daytime sleepiness is a typical symptom in adolescents 
with OSAS, whereas hyperactivity or inattention is predominant in 
preadolescent children with sleep-disordered breathing. Morning 
headaches and poor appetite may present in OSAS, which may 
be due to carbon dioxide retention, sleep fragmentation, or 
gastroesophageal reflux. 
Sequelae of OSAS
Untreated pediatric OSAS can result in serious morbidity in 
neurobehavioral, cardiovascular, and somatic growth and de-
velopment. Many studies have shown evidence for clear associations 
between OSAS and hyperactivity, attention deficit, and other 
behavioral problems such as social withdrawal or aggression
42-45). The 
prevalence of attention deficit/hyperactivity (ADHD) in the school-
Table 1. Common Symptoms and Signs of Pediatric OSAS by Age
Infants, 3–12 months Toddlers, 1–3 years Preschool-aged children School-aged children
Disturbed nocturnal sleep with
repetitive crying
Noisy breathing or snoring
Nocturnal sweating
Poor suck
Failure to thrive
Delayed development
Apparent life-threatening event
Noisy breathing or snoring
Restless nocturnal sleep
Abnormal sleeping positions
Nocturnal sweating
Mouth breathing
Night terrors
Poor eating 
Failure to thrive
Poor growth
Regular, heavy snoring
Mouth breathing
Restless nocturnal sleep
Sleepwalking
Night terrors
Enuresis
ADHD-like symptoms
Increased need for napping
Poor eating
Growth problems
Regular, heavy snoring
Restless nocturnal sleep
Sleepwalking
Sleep talking
Excessive bruxism
Difficulty to wake up in the morning
Morning headache
Poor appetite
Excessive daytime sleepiness Aggressiveness
Emotional instability
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age population is 8-10%
46), while 20-30% of children with snoring 
and/or OSAS have clinically significant problems with inattention 
and hyperactivity
47). This ADHD-like features in children with 
OSAS may result from repeated sleep disruptions and intermittent 
hypoxic episodes that affect prefrontal executive function such 
as working memory, behavioral control, analysis, organization, 
and self-regulation of motivation
42, 48). The prefrontal cortex is 
also believed to be responsible for the regulation of arousal, sleep, 
affect, and attention, as well as executive functions
49). Behavioral 
deficit and executive dysfunction in children with OSAS have 
been also shown to have negative impact on learning and school 
performance
50, 51). A number of studies have suggested that 
therapeutic intervention of OSAS such as adenoidectomy and/
or tonsillectomy have a significant improvement of not only 
the abnormal behaviors such as hyperactivity, inattention, and 
aggression but also cognition and school performance
47, 52-55). 
Cor pulmonale with heart failure and pulmonary hypertension 
were not an uncommon mode of presentation in children with a 
history of OSAS
56, 57); however, they are now rare due to early de-
tection and treatment of OSAS. Although obvious right heart failure 
now occurs less often, asymptomatic pulmonary hypertension 
may be common
58). Systemic hypertension can occur
57). The 
pathophysiology of cardiovascular complications is as follows: 
intermittent upper airway obstruction during sleep in OSAS 
patients that have induced an exaggeration of continuous negative 
intrathoracic pressure swings, leading to a second series of sus-
tained alterations of blood pressure and endothelial function, 
and eventually changes in cardiac structure and function occurs 
probably via oxidative stress and increased sympathetic tone
59-
65). Increased proinflammatory cytokine such as interleukin-6 or 
C-reactive protein have been noted in children with OSAS, which 
may be linked to endothelial dysfunction and atherogensis
66). It is 
suggested that systemic inflammation is a consequence of OSAS 
even in the absence of obesity, and is reversible after treatment 
of OSAS in most patients
67). Failure to thrive is not a common 
consequence of OSAS in children; however, growth spurt after 
adenotonsillectomy is commonly reported
68, 69). Growth failure is 
possibly related to a combination of anorexia and decreased oral 
intake, increased energy consumption from increased work of 
breathing, and alternations in nocturnal growth hormone secretion 
patterns
70, 71). Many studies have been shown that catch-up growth is 
related with increased secretion of insulin-like growth factor-1 (IGF-
1) and IGF-binding protein 3 (IGFBP-3) after adenotonsillectomy, 
both of which are highly correlated with diurnal growth hormone 
secretion and reflect mean daily growth hormone levels
70, 72-74). 
Diagnosis
Diagnosis of OSAS in children is made on the basis of sleep 
history, physical examination, and polysomnographic findings 
Table 2. Diagnostic Criteria of Pediatric Obstructive Sleep Apnea by the AASM*
A. The caregiver of the child reports snoring, labored or obstructed breathing, or both snoring and labored or obstructed breathing during the child's sleep.
B. The caregiver reports observing at least one of the following:
1. Paradoxical inward rib-cage motion during inspiration
2. Movement arousals
3. Diaphoresis
4. Neck hypertension during sleep
5. Excessive daytime sleepiness, hyperactivity, or aggressive behavior
6. Morning headaches
7. Secondary enuresis
C. Polysomnographic recording demonstrates 1 or more scorable respiratory events per 
hour (i.e., apnea or hypopnea of at least 2 respiratory cycles in duration).
Note: Very few normative data are available for hypopneas, and the data that are available have been obtained using a variety of methodologies. These criteria 
may be modified in the future once more comprehensive data become available.
D. Polysomnographic recording demonstrates either 1 or 2.
1. At least one of the following is observed:
a. Frequent arousals from sleep associated with increased respiratory effort
b. Arterial oxygen desaturation in association with the apneic episodes
c. Hypercapnia during sleep
d. Markedly negative esophageal pressure swings
2. Periods of hypercapnia, desaturation, or hypercapnia and desaturation during sleep associated with snoring, paradoxical inward rib-cage motion during 
    inspiration, and at least one of the following:
a. Frequent arousals from sleep
b. Markedly negative esophageal pressure swings
E. The disorder is not better explained by another current sleep disorder, medical or neurological disorder, medication use, or substance use disorder.
*American Academy of Sleep Medicine
75)Korean J Pediatr 2010;53(10):863-871 • DOI: 10.3345/kjp.2010.53.10.863    867
(Table 2)
75). OSAS should be suspected on parental complaints 
about their children's sleep. Frequent napping or excessive sleepiness 
in the classroom is a major clue to sleep problems in older children. 
Clinicians can use a sleep log, sleep diary, or sleep questionnaire 
to efficiently identify the traits of a patient's sleep. Although a 
thorough history of sleep is very important in the diagnosis of sleep 
disorders, studies have shown that OSAS cannot be differentiated 
from primary snoring by history alone
1). A comprehensive physical 
examination of the upper airway from the nose to the oropharynx 
can help find any anatomical narrowing; that is, a deviated nasal 
septum, enlarged inferior turbinate, overcrowding of teeth, 
enlargement of adenoid with/without tonsillar hypertrophy, or 
the presence of a high and narrow hard palate. Mallampati score 
is helpful in evaluating the patency of airway related to tonsil size, 
particularly for older and obese children
76) (Fig. 1). An adenoid 
face with mouth breathing at the waking state is an important clue 
in detecting sleep-disordered breathing. Inspection of the lateral 
facial profile is helpful to evaluate for retrognathia, micrognathia, or 
midfacial hypoplasia. 
In advanced cases of OSAS, a loud second pulmonary heart 
sound may manifest as an evidence of pulmonary hypertension
63). 
Assessment for growth and development should not be omitted 
because growth impairment and delayed development are 
frequently associated in children with OSAS
77). Paranasal sinus with 
neck lateral view in X-ray is a simple but very useful method for the 
detection of sinusitis or adenoid hypertrophy (Fig. 2). Endoscopy 
performed under sedation is useful in localizing the region of 
maximal airway restriction. This technique is reserved for children 
with complicated airway structure and altered collapsibility such as 
congenital craniofacial anomaly
78). 
Polysomnography
The American Academy of Pediatrics (AAP) suggested a clinical 
guideline for childhood OSAS in 2002
56) (Table 3). The AAP re-
commended polysomnography (PSG) as the only gold standard 
method for the diagnosis of pediatric OSAS. While they accepted 
the use of audiovisual taping and pulse oximetry recording as 
screening studies for OSAS, PSG should be followed in clinically 
suspected children if these screening tests do not support 
OSAS. A guideline for PSG in children is recommended by the 
American Academy of Sleep Medicine (AASM) in 2007 (Table 
4)
79). Supervision by a trained technician is required throughout 
the study, with additional record keeping of unusual events or 
behaviors during the night. An extended full EEG channel is useful 
for differentiation of nocturnal seizure disorders (e.g., nocturnal 
Fig. 1. Mallampati score. Class 1: full visibility of tonsils, uvula, and soft 
palate. Class 2: visibility of hard and soft palate, upper portion of tonsils, 
and uvula. Class 3: soft and hard palate and base of the uvula are 
visible. Class 4: only hard palate is visible. Higher scores are correlated 
with having OSAS.
Fig. 2. Neck lateral view. The enlarged adenoid and tonsils are easily 
noted in this film.
Table 3. Clinical Guideline for Childhood OSAS*
All children should be screened for snoring.
Complex high-risk patients should be referred to a specialist.
Patients with cardiorespiratory failure cannot await elective evaluation.
Diagnostic evaluation is useful in discriminating between primary snoring and 
OSAS, the gold standard being polysomnography.
Adenotonsillectomy is the first line of treatment for most children, and 
continuous positive airway pressure is an option for those who are not 
candidates for surgery or do not respond to surgery.
High-risk patients should be monitored as inpatients postoperatively.
Patients should be reevaluated postoperatively to determine whether 
additional treatment is required.
*The American Academy of Pediatrics (AAP) have developed a clinical 
guideline for childhood OSAS in 2002
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frontal lobe epilepsy) from parasomnias such as sleepwalking. End-
tidal CO2 measurement can also help assess gas exchange. This is 
particularly important in children with obesity or neuromuscular 
diseases, who have a higher risk for hypoventilation
78). Balloon 
esophageal manometry, which can detect upper airway resistance 
by measuring the intrathoracic negative pressure, is now rarely 
used in children due to intolerability. New techniques such as pulse 
transit time or cyclic alternating pattern on EEG are becoming 
more convenient tools to detect arousals during PSG. These 
methods are more sensitive and may predict neurocognitive and/or 
cardiovascular outcomes in children with OSAS
80-82). 
The PSG parameters that are mostly used in evaluating for OSAS 
are the apnea-hypopnea index (AHI), apnea index (AI), respiratory 
event-related arousals (RERAs), and respiratory disturbance index 
(RDI). AHI indicates the number of apneic and hypopneic events 
per hour of sleep. Apnea is defined as a complete interruption of 
airflow lasts at least 2 breath periods in children or 10 seconds 
in adult, whereas hypopnea is defined as a ≥50% reduction in 
airflow with an arousal, awakening, or ≥3% desaturation for same 
durations by using a nasal cannula-pressure transducer
79) (Fig. 3). 
AI indicates the number of obstructive and/or central apneic events 
per hour of sleep. RERA is defined as a sequence of breath lasts at 
least 2 breath periods, which does not meet the criteria for apnea 
or hypopnea but is accompanied by increasing respiratory effort, 
leading to an arousal from sleep. The AHI and RERA may be 
reported together as the RDI. The diagnosis of OSAS in children is 
defined as AHI index >1, according to the criteria of the AASM
75), 
although different criteria for childhood OSAS, such as AI >1 or 
RDI >1.5, have been suggested in several studies
39, 83). Sleep-related 
hypoventilation may be scored when >25% of the total sleep time 
is spent with a CO2 >50 mm Hg, measured by end-tidal CO2 
(PETco2) and/or transcutaneous CO2 (Ptco2) sensors
79, 84) (Table 
5). It should be noted that common PSG parameters such as AI, 
AHI, RDI, and the nadir of oxygen saturation (SpO2) are helpful 
in evaluating the severity of OSAS, but they may not completely 
identify sleep-disordered breathing in children since PSG has not 
Table 4. Polysomnographic Variables recommended by the AASM*
Electroencephalogram (EEG) activity: F4-M1, C4-M1, and O2-M1 with backup 
(F3-M2, C3-M2, and O1-M2)
Eye movements (electrooculogram) from electrodes placed near the outer 
canthus of each eye. 
Submental electromyographic (EMG) activity from electrodes placed over the 
mentalis, submentalis muscle, and/or masseter regions.
Electrocardiogram (EKG) with 1 lead II electrode or more chest leads at the 
discretion of the provider.
Respiratory effort, by chest wall and abdominal movement via inductive 
plethysmography, impedance or inductance pneumography, or endo-
esophageal pressure. 
Nasal and/or oral airflow via thermistor, nasal pressure transducer, or 
pneumotachograph or inductance plethysmography.
Oxygen saturation (SPO2) via pulse oximetry including waveform, with an 
averaging time of no more than 3 seconds.
End-tidal CO2 (PETco2) or transcutaneous CO2 (Ptcco2).
Body position via sensor and by direct observation.
Limb movements (right and left anterior tibialis) via EMG.
Recording of snoring or vibration (frequency and/or volume).
Audio/video recording by infrared or low-light equipment.
*AASM: American Academy of Sleep Medicine
79)
F: frontal electrode; M: mastoid electrode; C: central electrode; O: occipital 
electrode.
Fig. 3. Obstructive hypopnea (60-second PSG epoch) in REM sleep. The event (arrow) 
was initiated by diminished nasal pressure airflow (PTAF) accompanied by paradoxical 
respiration leading to arousal. This respiratory event was associated with a ≥50% 
decrease in the amplitude of the nasal pressure signal. Ocular movement is seen on the 
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been well standardized in its performance or interpretation
56). Other 
important clinical parameters such as paradoxical respiration, 
duration of abnormal sleep position, and frequency of body position 
change may be quantified and included as criteria for the diagnosis 
of childhood OSAS
85). Therefore, a thorough validity study for 
current PSG parameters with the development of new diagnostic 
criteria for pediatric OSAS is mandatory. 
Conclusion
Pediatric OSAS has been commonly overlooked and under-
diagnosed by both parents and clinician until now. Clinicians 
should be familiar with the manifestations of OSAS because 
children have various clinical symptoms and signs according 
to their developmental stages. OSAS in children are also 
different from OSAS in adults, in particular with respect to 
pathophysiology, gender distribution, and nocturnal and daytime 
symptoms. Children with OSAS but were not treated may have 
serious morbidities such as neurobehavioral, cardiovascular, 
and impairment of growth and development, most of which are 
reversible by early detection and treatment. Although clinical 
parameters in the pediatric PSG field are still evolving, PSG is a 
good diagnostic tool for the diagnosis of pediatric OSAS. 
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